78 results on '"Renshaw, Andrew A."'
Search Results
2. Document Version Control in the Pathology Laboratory: Git Is an Open-Source Option
3. In Response to 'Overdiagnosis of Thyroid Cancer: Is This Not an Ethical Issue for Pathologists As Well As Radiologists and Clinicians?'
4. Synoptic Report Response Options Directly Impact Patient Care
5. Root Cause Analysis of Amendments in Tumor Summaries
6. Challenges for Data Extraction From Narrative Pathology Reports
7. An estimate of risk of malignancy for a benign diagnosis in thyroid fine-needle aspirates
8. Should 'atypical follicular cells' in thyroid fine-needle aspirates be subclassified?
9. Do Synoptic Reports Add Value in Prostate Needle Biopsies?
10. Increasing cytotechnologist workload above 100 slides per day using the ThinPrep imaging system leads to significant reductions in screening accuracy
11. Does the time of day or weekday affect screening accuracy? A pilot correlation study with cytotechnologist workload and abnormal rate detection using the ThinPrep imaging system
12. Updates and Customizations in Synoptic Reporting
13. Measuring the significance of workload on performance of cytotechnologists in gynecologic cytology: a study using rapid prescreening
14. Comparison of Accuracy and Speed of Information Identification by Nonpathologists in Synoptic Reports With Different Formats
15. The Cost of Synoptic Reporting
16. Comparison of ureteral washing and biopsy specimens in the community setting
17. Results of multiple-slide, blinded review of Papanicolaou slides in the context of litigation: determining what can be detected regularly and reliably
18. Atypical cells in fine-needle aspiration biopsy specimens of benign thyroid cysts
19. Blinded review of Papanicolaou smears in the context of litigation; using statistical analysis to define appropriate thresholds
20. Hurthle cell carcinoma is a better gold standard than hurthle cell neoplasm for fine-needle aspiration of the thyroid: defining more consistent and specific cytologic criteria
21. 'Histiocytoid' cells in fine-needle aspirations of papillary carcinoma of the thyroid: frequency and significance of an under-recognized cytologic pattern
22. Measuring sensitivity in gynecologic cytology: a review
23. Reducing or eliminating use of the category of atypical squamous cells of undetermined significance decreases the diagnostic accuracy of the Papanicolaou smear
24. Estimating the percentage of Papanicolaou smears that can be reproducibly identified: modeling Papanicolaou smear interpretation based on multiple blinded rescreenings
25. An accurate and precise methodology for routine determination of the false-negative rate of Papanicolaou smear screening
26. The human false-negative rate of rescreening Pap tests
27. Subclassifying atypical urinary cytology specimens
28. Cytologic analysis of renal angiomyolipoma: a comparison of radiologically classic and challenging cases
29. Improved Intraoperative Smears
30. Interpretive Diagnostic Error Reduction in Surgical Pathology and Cytology: Guideline From the College of American Pathologists Pathology and Laboratory Quality Center and the Association of Directors of Anatomic and Surgical Pathology
31. Causes of death in men undergoing androgen suppression therapy for newly diagnosed localized or recurrent prostate cancer
32. Cytologic analysis of papillary renal cell carcinoma
33. Effusion cytology of renal cell carcinoma
34. Duration of testosterone suppression and the risk of death from prostate cancer in men treated using radiation and 6 months of hormone therapy
35. Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer
36. Effusion cytology of esophageal carcinoma
37. Analysis of error in calculating the false-negative rate in the interpretation of cervicovaginal smears: the need to review abnormal cases
38. A more accurate measure of the false-negative rate of Papanicolaou smear screening is obtained by determining the false-negative rate of the rescreening process
39. Use of statistical analysis of cytologic interpretation to determine the causes of interobserver disagreement and in quality improvement
40. Fine-needle aspiration of chromophobe renal cell carcinoma: analysis of six cases
41. Fine-needle aspiration of the adult kidney
42. Prostate-specific antigen recurrence and mortality after conventional dose radiation therapy in select men with low-risk prostate cancer
43. The impact of a delay in initiating radiation therapy on prostate-specific antigen outcome for patients with clinically localized prostate carcinoma
44. Intermediate end point for prostate cancer-specific mortality following salvage hormonal therapy for prostate-specific antigen failure
45. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era
46. Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high-risk prostate cancer
47. Strategies for improving gynecologic cytology screening
48. Seeking a silver lining: improving the performance of gynecologic cytology in a lower volume setting
49. Choosing battles or excuses in gynecology cytology
50. Pathologic findings and prostate specific antigen outcome after radical prostatectomy for patients diagnosed on the basis of a single microscopic focus of prostate carcinoma with a Gleason score less than or equal to 7
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.